1 / 10

BioDiscovery Toronto @

BioDiscovery Toronto @. May 5 , 2005. 1. What kind of policy instruments can shape the evolution of clusters?. “Institutions for Collaboration” / “Fourth Pillar Organizations” - central to the concept of clusters (Porter) - focus of Biotechnology Cluster Innovation Program

eagan-wolf
Download Presentation

BioDiscovery Toronto @

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BioDiscovery Toronto @ May 5 , 2005

  2. 1. What kind of policy instruments can shape the evolution of clusters? “Institutions for Collaboration” / “Fourth Pillar Organizations” - central to the concept of clusters (Porter) - focus of Biotechnology Cluster Innovation Program • The MaRS Discovery District represents an investment to create ‘physical capital’ in the form of a ‘hub’ organization for the commercialization of discoveries in the medical and related sciences. • BioDiscovery Toronto represents an investment to create ‘social capital’ at MaRS through leveraging the business development capacity of 8 research hospitals and universities and providing a two-way interface with the bio-finance and bio-medical industries.

  3. BioDiscovery Toronto Mandate To maximize commercialization of research in Toronto by linking research, industry and capital Focus Provision of a fully functional central interface between the research community and industry as well as a facilitator of cross-institutional activity

  4. 2. What are policy outcomes & can they be linked to specific policy initiatives • Networking that yields better leverage, focus, continuity, cohesion • Better opportunities to bundle IP • Clearer ‘branding’ • A dynamic public-private interface • ….. still missing is any real direct policy support for ‘downstream’ private sector initiatives

  5. 3. What mechanisms enable multi-level governance in the cluster? • IFCs are probably the best mechanism going • Too many levels of governance in Canada! • Should we really need such mechanisms? • Our approach is to try and collapse these!!

  6. 4. What place do they leave for private sector participants? • Clusters are largely defined by the private sector • Reverse the question … instead of asking ‘what place is left in cluster governance mechanisms for the private sector?’ • We should be asking ‘what mechanisms do the private sector believe to be necessary for development of their cluster?’

  7. 5. Do we need a better science/cluster policy ‘process’ in Canada? • Tendency to be focus on ‘ex post’ issues • presumably because science policy in Canada is very much a process of ‘revealed preferences’. • Should we not be concerned with the development of a more robust and transparent science and cluster policy process? • not only for Life Sciences but for all areas affecting innovation systems?

  8. Supplementary slides

  9. Ontario’s Life Sciences Gateway Technology-based SMEs Entrepreneurs Researchers pursuing commercial opportunities Toronto Ottawa & Eastern Ontario Guelph London Western GTA Northern Ontario Southwest Ontario Waterloo Golden Horseshoe York Region Peterborough Kingston • Regional Innovation Networks • Align Regional Resources (address gaps) • Leverage Federal Funding • Linkages to business support infrastructure • Linkages to Research Infrastructure • MaRS • Knowledge Management System (Gateway to the World) • RIN Support e-tools (MaRS Web Portal) • Domestic / International VC Connections • Commercialization Initiatives (Province Wide)

  10. BioDiscovery Toronto Operational Model Inputs Customers BioDiscovery Toronto Institution for Collaboration Industry Member Institutions Member Institutions Tech Transfer Market analysis (internal/external) Best practices & professional development Capital

More Related